PEPTARA LABS
Get Started
Peptara Labs AHK-Cu 100mg vial
Copper Tripeptide

AHK-Cu Peptide for Sale

Published by · Updated · How we research and check our pages

Ala-His-Lys Bound to Copper, Studied in Labs

AHK-Cu peptide from Peptara Labs (peptaralabs.io) is a 100mg research vial of alanyl-histidyl-lysine bound to copper, a close relative of GHK-Cu. It costs $50 USD, at its pre-sale price: 50% off the regular $100 until October 15, 17:00 UTC. Its batch certificate of analysis is pending, so no purity figure is claimed yet. On pre-order: Ships October 28. It is sold as lyophilized powder for research use only.

$50 USDWas $100 USD

Pre-sale price, 50% off, ends October 15, 17:00 UTC

Flat $35 tracked shipping100mg per vial

Ships October 28

1vial

$50 USD

Was $100

$50.00 per vialWas $100.00pre-sale price

The pre-sale price applies at every quantity. No code or multi-vial pricing is added to it.

Batch certificate pending
Peptara Labs AHK-Cu 100mg vial

Shipping, delivery and certificate status

Shipping
Flat $35, tracked worldwide to supported markets
Delivery
Ships October 28 · After dispatch: 5 to 10 business days
Included
Vial · Batch certificate pending · Order support on WhatsApp

Buyer facts

What comes with AHK-Cu from Peptara Labs?

This listing is one sealed 100mg research vial of AHK-Cu powder. A finished cosmetic has a full formula and other ingredients; a research vial has a different identity and purpose. The pending certificate means this page has no measured purity or batch result to quote.

DetailPeptara Labs AHK-Cu (100mg)Where to check it
Vial100mg of lyophilized AHK-Cu powder in a sealed vialOrder panel
Price$50 USD, at its pre-sale price: 50% off the regular $100 until October 15, 17:00 UTCOrder panel
AvailabilityPre-order. Ships October 28Order panel
CertificateBatch certificate pendingCertificates of analysis
PurityNo purity figure is claimed while the batch certificate is pendingCertificate status
IdentityAla-His-Lys bound to copper, distinct from GHK-CuResearch sources below
Product formResearch powder vial, not a finished serumThis listing
Pre-sale price, 50% off, ends October 15, 17:00 UTC

Share or cite this page

Add as preferred on Google

Sources: Pyo et al., 2007, Archives of Pharmacal Research; PubChem CID 7408502.

Before you buy

What should be checked before buying AHK-Cu?

Check the peptide identity and the copper content separately. AHK-Cu is a copper complex. A test that finds only the bare Ala-His-Lys peptide does not settle whether the sample matches that name. The label also needs to distinguish AHK-Cu from its close relative GHK-Cu.

  • Peptide identity: a mass test can help identify the peptide. The reference formula for bare Ala-His-Lys is C15H26N6O4, with a molecular weight of about 354.41 g/mol. Those are reference facts, not measurements of this batch.
  • Copper content: the copper complex and the bare peptide are different materials. The complex weight depends on its salt form, so this page does not assign it the bare peptide's weight.
  • Purity: HPLC measures purity, while identity testing answers a different question. A purity number alone does not identify the compound.
  • Batch evidence: the AHK-Cu certificate is pending. No completed identity test, copper result or purity figure is claimed for this vial.

The certificates page is the place to check the batch status. A research paper explains a molecule; it does not certify the material in an order.

Sources: Pyo et al., 2007, Archives of Pharmacal Research; PubChem CID 7408502.

The short answer

What is AHK-Cu?

AHK-Cu is a three-amino-acid peptide bound to a copper(II) ion. Its peptide sequence is alanine, histidine and lysine, written Ala-His-Lys. GHK-Cu starts with glycine instead of alanine. That one change matters when reading a paper: evidence about one name does not become evidence about the other.

The most relevant AHK-Cu study examined isolated follicles and cultured cells in a lab. Its authors measured follicle length, cell growth and cell-death markers. The study did not test a finished serum or measure hair changes in people.

Sources: Pyo et al., 2007, Archives of Pharmacal Research; PubChem CID 7408502; Pickart and Margolina, 2018, International Journal of Molecular Sciences.

The Science

How AHK-Cu works in research models

The study focused on dermal papilla cells, which sit at the base of a hair follicle. Researchers examined whether AHK-Cu changed cell growth and signals linked to cell death. These are clues about a lab model, rather than a complete explanation of how the compound behaves.

The paper's background described fibroblast growth, more VEGF and less TGF-beta1 after study of the tripeptide-copper complex. VEGF is linked to blood-vessel biology, and TGF-beta1 is a cell signal. These background statements are separate from the follicle experiment's own findings.

Dermal papilla cells

Cells multiplied in culture in the AHK-Cu experiment. The authors proposed that these cells helped explain the follicle observation.

Cell-death markers

The Bcl-2/Bax ratio rose, while cleaved caspase-3 and PARP fell. These markers describe changes inside the cultured cells.

A limit in the data

The drop in dying cells was not statistically significant. That finding carries less weight than a confirmed change.

Sources: Pyo et al., 2007, Archives of Pharmacal Research.

Research areas

Common research areas

Isolated follicle biology

Follicles kept alive outside the body let researchers measure length in a controlled model. That model leaves many real-world questions open.

Dermal papilla cell culture

Cells grown in dishes were examined for growth and cell-death markers. Cell culture cannot reproduce a whole living system.

Copper-peptide chemistry

The bare peptide, its copper complex and its salt form need separate identities. A clear chemical name helps keep those records apart.

Cosmetic formulation research

This field studies ingredients within finished formulas. A powder vial and a finished formula are separate products, with separate evidence.

Sources: Pyo et al., 2007, Archives of Pharmacal Research; PubChem CID 7408502.

Comparison

How does AHK-Cu compare with GHK-Cu?

AHK-Cu and GHK-Cu share two amino acids and both bind copper. Their names are often placed together, but their evidence records differ. The table compares the compounds without treating either as a substitute for the other.

DetailAHK-CuGHK-Cu
SequenceAla-His-Lys bound to copperGly-His-Lys bound to copper
Research recordOne indexed paper in the dated AHK-Cu checkA larger literature summarized in the 2018 review
Work described hereIsolated follicles and dermal papilla cellsSkin, tissue and gene-expression research
Catalog vial100mg100mg

The GHK-Cu page covers the sibling compound. The copper-peptide hair research guide explains the follicle paper in more detail, while the hair research overview puts that paper beside other evidence.

Sources: Pyo et al., 2007, Archives of Pharmacal Research; Pickart and Margolina, 2018, International Journal of Molecular Sciences; NCBI PubMed search, October 7, 2026.

Evidence

What did the AHK-Cu study measure?

The 2007 paper used two lab models: isolated human hair follicles and cultured dermal papilla cells. Follicles grew longer in the experiment, and cells multiplied in dishes. The authors proposed a link through dermal papilla cells. No person's hair growth was measured.

Isolated follicle experiment

Model: human follicles kept alive outside the body.

Measured: follicle length. The reported change belongs to this lab model.

Cultured-cell experiment

Model: dermal papilla cells in culture.

Measured: cell growth and cell-death markers. The count of dying cells fell without reaching statistical significance.

The marker results and the cell count answer different questions. A change in a marker does not erase a weak result in another measure. Both belong in a fair account of this study.

Sources: Pyo et al., 2007, Archives of Pharmacal Research.

What is not known

What is not known about AHK-Cu?

The October 7, 2026 PubMed check found no study in people, no animal study and no published AHK-Cu half-life or safety data. One lab paper cannot fill those gaps. It also cannot establish the safety or effectiveness of this catalog vial.

Half-life describes how quickly a measured amount falls by half in a stated system. This page gives no AHK-Cu half-life because the paper has no such measurement. A value borrowed from GHK-Cu would describe another molecule.

AHK-Cu evidence ledger

A PubMed search for AHK-Cu on October 7, 2026 returned one paper. The search used the exact name AHK-Cu, so it may miss papers indexed under other names. The follicle paper tested AHK-Cu. It should not be cited as a direct GHK-Cu follicle experiment.

Sources: Pyo et al., 2007, Archives of Pharmacal Research; NCBI PubMed search, October 7, 2026.

Research Timeline

How the AHK-Cu record was built

Research timeline

How the AHK-Cu record was built

2007: follicle and cell models

A study examined isolated human hair follicles and cultured dermal papilla cells. The work remains the main indexed AHK-Cu study in the dated search.

2018: the sibling review

A GHK-Cu review covered skin and gene-expression research. That is evidence about GHK-Cu and does not add a second AHK-Cu study.

2026: the evidence check

The October 7 PubMed check returned one AHK-Cu paper. This page separates that narrow record from the wider copper-peptide literature.

Your Kit

What's Included

AHK-Cu research vial

$50 USD Was $100 USD

Flat $35 tracked shipping · Ships October 28 · Batch certificate pending · Order support on WhatsApp

Pre-sale price, 50% off, ends October 15, 17:00 UTC

Order AHK-Cu

AHK-Cu 100mg Vial

100mg per vial

Batch certificate

Batch certificate pending

Delivery

Ships October 28 · After dispatch: 5 to 10 business days

Order support

Contact our team about your order or batch certificate.

Your order includes the vial. Batch certificate pending. Delivery details are confirmed with your order. Order support is available on WhatsApp.

Research vial
Batch certificate pending
Delivery information with your order
Order support

Your order includes the vial. Batch certificate pending. Delivery details are confirmed with your order. Order support is available on WhatsApp.

Research vial
Batch certificate pending
Delivery information with your order
Order support

Your order includes the vial. Batch certificate pending. Delivery details are confirmed with your order. Order support is available on WhatsApp.

Your Research Order

AHK-Cu research vial, batch certificate status, delivery and order support.

Batch certificate

Batch certificate pending

Delivery

Ships October 28 · After dispatch: 5 to 10 business days

Order support

Contact our team about your order or batch certificate.

Order AHK-Cu

Research and citations

Research sources

  1. Pyo et al., 2007, Archives of Pharmacal Research. Hair follicles and dermal papilla cells in laboratory models. PMID 17703734. https://doi.org/10.1007/BF02978833
  2. PubChem CID 7408502. Alanyl-histidyl-lysine, the peptide without copper. https://pubchem.ncbi.nlm.nih.gov/compound/7408502
  3. Pickart and Margolina, 2018, International Journal of Molecular Sciences. A review of GHK-Cu research, used here for the sibling comparison. PMID 29986520. https://doi.org/10.3390/ijms19071987
  4. NCBI PubMed search, October 7, 2026. The search for AHK-Cu returned one indexed paper, PMID 17703734. https://pubmed.ncbi.nlm.nih.gov/?term=AHK-Cu

Buying AHK-Cu: FAQ

Where can AHK-Cu peptide be bought?

Peptara Labs lists AHK-Cu at peptaralabs.io as a sealed 100mg research vial. It is on pre-order. Ships October 28. Its batch certificate is pending.

What is the AHK-Cu price per vial?

A sealed 100mg AHK-Cu vial costs $50 USD, at its pre-sale price: 50% off the regular $100 until October 15, 17:00 UTC. Ships October 28. Batch certificate pending. Research use only.

What comes with an AHK-Cu order?

One sealed 100mg vial of lyophilized AHK-Cu powder. Batch certificate pending. Delivery details are confirmed with the order, and order support is available on WhatsApp.

When does AHK-Cu ship?

Ships October 28. That date marks the start of dispatch. Transit time follows dispatch, and the order confirmation carries delivery details.

Is there a published AHK-Cu certificate?

No. The batch certificate of analysis is pending. No purity figure, test result or certificate date is claimed for this batch.

AHK-Cu FAQ

What is AHK-Cu peptide?

AHK-Cu is a copper peptide made of alanine, histidine and lysine bound to a copper ion. It is a close relative of GHK-Cu, with alanine in place of glycine.

What has AHK-Cu been studied for?

One lab study examined isolated human hair follicles and dermal papilla cells, the cells at the base of a follicle. The October 7, 2026 PubMed check returned that one paper. It did not test a product in people.

Does AHK-Cu affect hair growth?

In the 2007 lab study, isolated follicles grew longer and dermal papilla cells multiplied in dishes. These observations describe a lab model. They do not establish a hair-growth result in people.

Is AHK-Cu the same as GHK-Cu?

No. They differ by one amino acid. AHK-Cu has alanine where GHK-Cu has glycine. GHK-Cu has a larger research record, and findings about it cannot be assigned to AHK-Cu.

Is an AHK-Cu vial the same as an AHK-Cu serum?

No. A serum is a finished cosmetic with other ingredients. This listing is a sealed 100mg vial of lyophilized AHK-Cu powder for laboratory research. It is not a finished hair or skin product.

Is AHK-Cu sold as a medicine?

Peptara Labs sells AHK-Cu as laboratory research material only. The lab study on this page does not establish medical safety or effectiveness.

Sources: Pyo et al., 2007, Archives of Pharmacal Research; PubChem CID 7408502; Pickart and Margolina, 2018, International Journal of Molecular Sciences; NCBI PubMed search, October 7, 2026.

Order AHK-Cu, 100mg vial

Order AHK-Cu. Ships October 28 · After dispatch: 5 to 10 business days. Order support on WhatsApp.

Order Now

Batch certificate pending · Ships October 28 · Order support on WhatsApp

For research and educational purposes only. Peptara Labs is not a medical provider and this is not medical advice. These statements and products have not been evaluated by the FDA or any equivalent regulator and are not intended to diagnose, treat, cure, or prevent any disease. Research material only, not for human consumption. See our Medical Disclaimer and Terms.